セルライト治療市場：タイプ別、手技タイプ別、最終用途別-2025-2030年の世界予測

セルライト治療市場の2023年の市場規模は35億8,000万米ドルで、2024年には39億1,000万米ドルに達すると予測され、CAGR 9.59％で成長し、2030年には68億1,000万米ドルに達すると予測されています。

セルライト治療市場は、美容への関心の高まりと技術の進歩によって拡大しています。セルライトは、皮膚表面下の脂肪沈着による皮膚のくぼみを特徴とする美容上の症状であり、主に女性が罹患します。セルライト治療の必要性は、美の基準や自己イメージの意識の高まりに起因しており、皮膚の見た目の改善を求めることを余儀なくされています。この分野での応用は、局所治療、レーザー治療や高周波のような低侵襲処置から、サブシジョンのような外科的オプションまで多岐にわたる。最終用途分野には、皮膚科や美容クリニック、メディカル・スパ、家庭用機器を備えたホームケアなどがあります。

市場成長を促進する主な要因としては、可処分所得の増加、健康とウェルネスに対する意識の高まり、治療効果の向上とダウンタイムの短縮を提供する技術革新などが挙げられます。しかし、潜在的な成長機会は、AI主導の診断・治療ツールのような先進技術の統合や、非侵襲的で手頃な価格の利用しやすい選択肢による製品ポートフォリオの拡大にあります。このような機会があるにもかかわらず、市場は、先進治療の高額な費用、副作用の可能性や治療効果のばらつき、市場参入を制限する可能性のある厳しい規制要件などの制約に直面しています。

市場機会を活用するために、企業はより安全で効果的、かつコスト効率の高い治療を革新するための研究開発投資に注力すべきです。皮膚科医と協力して臨床試験を行い、推薦を得ることで、製品の信頼性をさらに高めることができます。また、AIや機械学習を活用し、個々の肌タイプや状態に合わせたパーソナライズド治療プランも技術革新の余地がある分野です。さらに、遠隔皮膚科サービスの世界の推進は、特に十分なサービスを受けていない地域において、市場拡大の新たな道を開く可能性があります。市場競争は激しくダイナミックであり、非侵襲的なソリューションがトレンドであるため、継続的なイノベーションと美容とウェルネスにおける消費者動向との整合性の重要性が強調されます。

市場力学：急速に進化するセルライト治療市場の主要市場インサイトを公開

セルライト治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 肥満の有病率の上昇
  • 外見に対する消費者の注目の高まり
  • 消費者の間での低侵襲手術の人気
• 市場抑制要因
  • セルライト治療の認知度と利用しやすさの制限
• 市場機会
  • 外用抗セルライトクリームと高周波治療の開発
  • 手頃な価格の美容外科手術を提供する経済圏の医療ツーリズム
• 市場の課題
  • 手術や処置による副作用の可能性

ポーターの5つの力：セルライト治療市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：セルライト治療市場における外部からの影響の把握

外部マクロ環境要因は、セルライト治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析セルライト治療市場における競合情勢の把握

セルライト治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスセルライト治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、セルライト治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨セルライト治療市場における成功への道筋を描く

セルライト治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 肥満率の上昇
    • 消費者の外見への関心の高まり
    • 消費者の間での低侵襲手術の人気
  • 抑制要因
    • セルライト治療の認知度とアクセスのしやすさが限られている
  • 機会
    • 局所用抗セルライトクリームと高周波療法の開発
    • 手頃な価格の美容外科手術を提供する経済圏における医療ツーリズム
  • 課題
    • 手術や処置による副作用の可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 セルライト治療市場：タイプ別

• 浮腫性セルライト
• 硬いセルライト
• ソフトセルライト

第7章 セルライト治療市場手順の種類別

• 低侵襲
• 非侵襲的
• 話題

第8章 セルライト治療市場：最終用途別

• 美容整形外科センター
• 皮膚科クリニック
• 病院

第9章 南北アメリカのセルライト治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のセルライト治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのセルライト治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie, Inc.
• Alma Lasers Ltd.
• Beijing Sincoheren S & T Development Co., Ltd.
• Candela Corporation
• Cutera, Inc.
• Cymedics
• Cymedics GmbH & Co. KG
• Cynosure, Inc.
• Endo-Systems LLC
• Hologic Inc.
• Inceler Medikal Co. Ltd.
• Johnson & Johnson Services, Inc.
• Merz Pharma
• Merz Pharma GmbH & Co. KGaA
• Nestle S.A.
• Shanghai Fosun Pharmaceutical（Group）Co. Ltd
• Skinrex Co., Ltd.
• Venus Concept Inc.
• Zimmer Aesthetics, Inc.

LIST OF FIGURES

• FIGURE 1. CELLULITE TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. CELLULITE TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CELLULITE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CELLULITE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CELLULITE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CELLULITE TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CELLULITE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CELLULITE TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY EDEMATOUS CELLULITE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY HARD CELLULITE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY SOFT CELLULITE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY COSMETIC SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 146. CELLULITE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. CELLULITE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Cellulite Treatment Market was valued at USD 3.58 billion in 2023, expected to reach USD 3.91 billion in 2024, and is projected to grow at a CAGR of 9.59%, to USD 6.81 billion by 2030.

The cellulite treatment market is broadening, driven by increasing aesthetic concerns and technological advancements. Cellulite, a cosmetic condition marked by dimpled skin due to fat deposit beneath the skin's surface, primarily affects women. The necessity for cellulite treatment stems from heightened beauty standards and self-image consciousness, compelling individuals to seek improved skin appearance. Applications in this domain range from topical treatments and minimally invasive procedures like laser therapy and radiofrequency, to surgical options such as subcision. End-use sectors predominantly include dermatological and cosmetic clinics, medical spas, and homecare settings equipped with at-home devices.

Key factors driving market growth include rising disposable incomes, an increase in health and wellness awareness, and technological innovations offering enhanced treatment efficacy and reduced downtime. However, potential growth opportunities lie in integrating advanced technologies like AI-driven diagnostic and treatment tools, and expanding product portfolios with non-invasive, affordable, and accessible options. Despite these opportunities, the market faces constraints such as high costs of advanced treatments, possible side effects and varied treatment efficacy, and stringent regulatory requirements that may limit market access.

To capitalize on market opportunities, companies should focus on R&D investments to innovate safer, more effective, and cost-efficient treatments. Collaborations with dermatologists for clinical trials and gaining endorsements can further bolster product credibility. Another area ripe for innovation is personalized treatment plans that cater to individual skin types and conditions, leveraging AI and machine learning for precise customization. Furthermore, the global push towards tele-dermatology services could open new avenues for market expansion, especially in underserved regions. The nature of the cellulite treatment market is competitive and dynamic, with a trend towards non-invasive solutions, highlighting the importance of continuous innovation and alignment with consumer trends in beauty and wellness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cellulite Treatment Market

The Cellulite Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in the prevalence of obesity
  • Increasing consumer focus on physical appearance
  • Popularity of minimally invasive procedures among consumers
• Market Restraints
  • Limited awareness and accessibility of cellulite treatments
• Market Opportunities
  • Development of topical anti-cellulite creams and radiofrequency therapy
  • Medical tourism in economies delivering affordable aesthetic surgical procedures
• Market Challenges
  • Possible side effects of surgeries and procedures

Porter's Five Forces: A Strategic Tool for Navigating the Cellulite Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cellulite Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cellulite Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cellulite Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cellulite Treatment Market

A detailed market share analysis in the Cellulite Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cellulite Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cellulite Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cellulite Treatment Market

A strategic analysis of the Cellulite Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cellulite Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Alma Lasers Ltd., Beijing Sincoheren S & T Development Co., Ltd., Candela Corporation, Cutera, Inc., Cymedics, Cymedics GmbH & Co. KG, Cynosure, Inc., Endo-Systems LLC, Hologic Inc., Inceler Medikal Co. Ltd., Johnson & Johnson Services, Inc., Merz Pharma, Merz Pharma GmbH & Co. KGaA, Nestle S.A., Shanghai Fosun Pharmaceutical (Group) Co. Ltd, Skinrex Co., Ltd., Venus Concept Inc., and Zimmer Aesthetics, Inc..

Market Segmentation & Coverage

This research report categorizes the Cellulite Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Edematous Cellulite, Hard Cellulite, and Soft Cellulite.
• Based on Procedure Type, market is studied across Minimally Invasive, Non-Invasive, and Topical.
• Based on End-Use, market is studied across Cosmetic Surgery Centers, Dermatology Clinics, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in the prevalence of obesity
    • 5.1.1.2. Increasing consumer focus on physical appearance
    • 5.1.1.3. Popularity of minimally invasive procedures among consumers
  • 5.1.2. Restraints
    • 5.1.2.1. Limited awareness and accessibility of cellulite treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of topical anti-cellulite creams and radiofrequency therapy
    • 5.1.3.2. Medical tourism in economies delivering affordable aesthetic surgical procedures
  • 5.1.4. Challenges
    • 5.1.4.1. Possible side effects of surgeries and procedures
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cellulite Treatment Market, by Type

• 6.1. Introduction
• 6.2. Edematous Cellulite
• 6.3. Hard Cellulite
• 6.4. Soft Cellulite

7. Cellulite Treatment Market, by Procedure Type

• 7.1. Introduction
• 7.2. Minimally Invasive
• 7.3. Non-Invasive
• 7.4. Topical

8. Cellulite Treatment Market, by End-Use

• 8.1. Introduction
• 8.2. Cosmetic Surgery Centers
• 8.3. Dermatology Clinics
• 8.4. Hospitals

9. Americas Cellulite Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cellulite Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cellulite Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie, Inc.
• 2. Alma Lasers Ltd.
• 3. Beijing Sincoheren S & T Development Co., Ltd.
• 4. Candela Corporation
• 5. Cutera, Inc.
• 6. Cymedics
• 7. Cymedics GmbH & Co. KG
• 8. Cynosure, Inc.
• 9. Endo-Systems LLC
• 10. Hologic Inc.
• 11. Inceler Medikal Co. Ltd.
• 12. Johnson & Johnson Services, Inc.
• 13. Merz Pharma
• 14. Merz Pharma GmbH & Co. KGaA
• 15. Nestle S.A.
• 16. Shanghai Fosun Pharmaceutical (Group) Co. Ltd
• 17. Skinrex Co., Ltd.
• 18. Venus Concept Inc.
• 19. Zimmer Aesthetics, Inc.